These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35247495)

  • 1. 'Be afraid - be very afraid': passive air drying of nebulizer parts in cystic fibrosis - occult microbiological risks of contamination with Pseudomonas aeruginosa from calyptrate flies (Musca domestica and Calliphora vomitoria).
    Moore JE; Millar BC
    J Hosp Infect; 2022 May; 123():193-194. PubMed ID: 35247495
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
    Moore JE; Moore RE; Bell J; Millar BC
    Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
    Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
    Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
    Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
    J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOBI: reducing the impact of pseudomonal infection.
    Govan J
    Hosp Med; 2002 Jul; 63(7):421-5. PubMed ID: 12187603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
    Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
    BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of the
    Moore JE; Millar BC
    Int J Mycobacteriol; 2020; 9(2):173-175. PubMed ID: 32474539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
    Hohenwarter K; Prammer W; Aichinger W; Reychler G
    J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home nebulizer use among patients with cystic fibrosis.
    Rosenfeld M; Emerson J; Astley S; Joy P; Williams-Warren J; Standaert TA; Yim DL; Crist D; Thykkuttathil M; Torrence M; FitzSimmons S; Ramsey B
    J Pediatr; 1998 Jan; 132(1):125-31. PubMed ID: 9470013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic therapy against Pseudomonas aeruginosa and other gram-negative bacteria in cystic fibrosis].
    Le Bourgeois M
    Arch Pediatr; 2003 Sep; 10 Suppl 2():352s-357s. PubMed ID: 14671934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
    Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
    J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudomonas aeruginosa and cystic fibrosis. Risks of contamination].
    Mouterde O; Massot J; Vassal S
    Arch Fr Pediatr; 1992 May; 49(5):476-7. PubMed ID: 1530450
    [No Abstract]   [Full Text] [Related]  

  • 14. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
    Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
    J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotics and nebulization].
    Diot P
    Arch Pediatr; 1999; 6 Suppl 2():169s-171s. PubMed ID: 10370468
    [No Abstract]   [Full Text] [Related]  

  • 17. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.
    Clifton IJ; Fletcher LA; Beggs CB; Denton M; Conway SP; Peckham DG
    J Cyst Fibros; 2010 Jan; 9(1):64-8. PubMed ID: 19944655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of contamination of single-patient-use nebulizers over time.
    Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
    Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
    Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
    J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Assael BM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.